CRVO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Diffusion Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 2.559 USD 0.75% Market Closed

Market Cap: $34.6m

D	Diffusion Pharmaceuticals Inc NASDAQ:CRVO	US
	China Gold International Resources Corp Ltd TSX:CGG	CA

Profitability Summary

Diffusion Pharmaceuticals Inc's profitability score is 3/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-9.407%

Negative 3Y Average Operating Margin

-1.115%

Declining Operating Margin

-314% > -9.407%

Negative Net Margin

-9.161%

Negative 3Y Average Net Margin

-1.053%

Declining Net Margin

-282% > -9.161%

Negative Free Cash Flow Margin

-8.445%

Negative 3Y Average Free Cash Flow Margin

-992%

Declining Free Cash Flow Margin

-442% > -8.445%

Negative ROE

-108%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.356%

Declining ROIC

4.468% > -2.029%

View All

Hide

Collapse

3 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.